Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-25 · accession 0000950170-24-131691 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-11-27 | 2024-11-25 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale+OE | $15.00 | -50.0K | 217.4K | -19% | -$750.0K |
| DT | 2024-11-27 | 2024-11-25 | WVE | BOLNO PAUL | Pres, CEO, Dir | M - OptEx | $2.48 | +50.0K | 267.4K | +23% | +$124.0K |
| DT | 2024-11-27 | 2024-11-25 | WVE | BOLNO PAUL | Pres, CEO, Dir | M - OptEx | $0.00 | -50.0K | 47.8K | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-11-25 | S | D | 50,000 | $15.00 | 217,351 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-11-25 | M | A | 50,000 | $2.48 | 267,351 | D | — | — | |
| 3 | Derivative | Share Option (right to buy) | 2024-11-25 | M | D | 50,000 | $0.00 | 47,778 | D | $2.48 · — to 2025-03-10 | 50,000 Ordinary Shares | (F2) These share options are fully vested. |